Hydration Pharmaceuticals Company LimitedASX: HPC

Letter to Shareholders regarding EGM

Sep 1, 2026 at 8:27 PM EDT · Issued by Hydration Pharmaceuticals Company Limited via ASX

Filed with ASX · Sep 1, 2026 at 8:27 PM EDT

On 6ix: 6ix.com/news/letter-to-shareholders-regarding-egm

8910 University Center Lane, Suite 400 San Diego, CA 92122 1 2 September 2026 Dear Shareholder THE HYDRATION PHARMACEUTICALS COMPANY LIMITED – UPCOMING EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS The Hydration Pharmaceuticals Company Limited (ACN 620 385...

View Attachment

6ix hasn’t read this filing yet.

Hydration Pharmaceuticals Company Limited on 6ix

Earlier from Hydration Pharmaceuticals

Notice of Extraordinary General Meeting/Proxy FormSep 1
Appendix 4D and FY26 Half Year Financial ReportAug 31
Q2 FY26 Quarterly Activities Report (App 4C)Jul 31
Capital raising, board renewal and management changesJun 14
Q1 FY26 Quarterly Activities Report (App 4C)Apr 30

Later from Hydration Pharmaceuticals

July and August 2026 Trading UpdateSep 28
Results of Extraordinary General MeetingOct 7
Rights Issue and UMP Share Sale FacilityOct 22
Prospectus - Non Renounceable Rights IssueOct 22
Letter to UMP Shareholders and Retention FormOct 22

All Hydration Pharmaceuticals news releases

Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.

Follow Hydration Pharmaceuticals